Covid-19 manufacturing roundup: Biden doubles down on vaccination plan with 100M-dose order; BioNTech, Pfizer ready to increase manufacturing; J&J experiences delivery woes
With headlines around the globe focused on various hitches in the global supply chain for Covid vaccines, President Joe Biden is taking out an insurance policy of sorts to help guarantee his promise to rapidly expand access.
Earlier in the week the president announced plans for a new contract with J&J covering an added 100 million doses of their one-shot jab to guard against Covid-19, to be delivered in the second half of the year. And much of that work will be done at Merck’sDurham, NC facility, which recently announced plans to expand its workforce by 100 at the 900,000-square-foot plant.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.